734
T. Iwai et al. / Tetrahedron: Asymmetry 24 (2013) 729–735
tography (15:1 to 5:1 hexane/EtOAc) to give diastereomeric
phosphates 9a (eluted first, 385 mg, 38%) and 9b (eluted later,
335 mg, 33%). Each diastereomer 9 (a light yellow solid) existed
as a mixture of atropisomers. The ratios (9a, 9:1; 9b, 7:3) were
determined by 1H NMR analysis. 9a: Mp: 115–118 °C. 1H NMR
(CDCl3): d 1.43 (s, 5.4H), 1.77 (s, 0.6H), 2.11 (s, 0.3H), 2.13 (s,
2.7H), 3.22 (br d, J = 12.1 Hz, 1H), 3.31 (d. J = 11.8 Hz, 0.3H),
3.48 (d, J = 11.8 Hz, 2.7H), 3.75 (t, J = 10.9 Hz, 1H), 4.60 (d,
J = 9.6 Hz, 1H), 6.23 (s, 1H), 6.32 (d, J = 8.0 Hz, 1H), 6.43 (s, 2H),
6.56 (t, J = 7.2 Hz, 1H), 6.76 (t, J = 7.4 Hz, 1H), 6.85–6.92 (m,
3H), 6.97–7.60 (m, 15H). 13C NMR (CDCl3): Due to the complexity
of the spectra, signal assignment based on the atropisomerism
and C–P couplings is difficult and not shown here. d 18.62,
20.22, 55.08, 55.28, 60.41, 60.50, 62.61, 62.81, 67.15, 67.21,
110.29, 110.62, 111.74, 111.83, 116.77, 116.85, 120.13, 123.50,
123.71, 125.95, 126.05, 126.96–129.03 (m), 129.52, 130.51,
131.28, 131.42, 131.62, 132.27, 132.62, 132.73, 140.77, 140.91,
141.05, 141.12, 141.36, 141.57, 144.83, 145.24, 155.96, 156.62,
156.87. 31P NMR (CDCl3): d 3.72 (minor), 3.13 (major). ESI-MS
(m/z): [M+H]+ 667.27. Anal. C42H39N2O4P, C 75.66, H 5.90, N
Due to the complexity of the spectra, signal assignment based on
the atropisomerism and C–P couplings is difficult and not shown
here. d 16.44, 16.90, 17.07, 18.99, 20.65, 20.71, 70.17, 74.38,
74.97, 75.24, 122.73, 122.78, 123.85, 124.09, 125.06, 128.10–
131.35 (m), 132.41–134.03 (m), 134.15, 135.24, 136.09, 136.97,
138.34, 138.78, 139.70, 148.84, 148.96, 149.14, 149.25, 151.36,
151.48, 151.62, 151.74, 161.04, 160.08, 161.50. 31P NMR (CDCl3):
d 5.94 (minor), 5.29 (major). HRMS-ESI (m/z): [M+Na]+ calcd for
C
42H35N2NaO4P, 685.22267; found, 685.22205. ½a D25
¼ þ19:55 (c
ꢂ
1.00, CHCl3).
4.2.8. Imidazolinium salt 11
Diaryl diamine 7 (50.3 mg, 0.081 mmol), CH(OEt)3 (0.54 mL,
3.23 mmol 40 equiv), and NH4BF4 (9.5 mg, 0.090 mmol 1.1 equiv)
were placed in a 10-mL Schlenk flask. The mixture was stirred at
110 °C for 10 h. After cooling to room temperature, the volatiles
were removed under vacuum. The residue was purified by silica
gel chromatography (CHCl3 then 20:1 CHCl3/MeOH) to give 11 as
a white solid (52.7 mg, 96% yield). The title compound 11 existed
as a mixture of atropisomers and the ratio (55:45) was deter-
mined by 1H NMR analysis. Mp: 139–143 °C. 1H NMR (CDCl3):
4.20; found, C 75.55, H 6.17, N 4.05. ½a D25
¼ ꢀ105:8 (c 1.01,
ꢂ
CHCl3). 9b: Mp: 212–213 °C. 1H NMR (CDCl3): d 1.65 (s, 3H),
1.72 (s, 3H), 2.10 (s, 3H), 3.14 (d, J = 11.6 Hz, 3H), 3.68 (d,
J = 11.6 Hz, 1H), 4.10 (br, 1H), 4.63 (br d, J = 8.2 Hz, 0.3H), 4.70
(dd, J = 8.8, 3.0 Hz, 0.7H), 5.47 (d, J = 2.8 Hz, 0.7H), 5.54 (br s,
0.3H), 6.36–6.42 (m, 1H), 6.49 (s, 0.6H), 6.52 (s, 1.4H), 6.69–
6.82 (m, 3H), 6.97–7.63 (m, 17H). 13C NMR (CDCl3): Due to the
complexity of the spectra, signal assignment based on the atrop-
isomerism and C–P couplings is difficult and not shown here. d
18.37, 18.61, 20.27, 20.29, 54.58, 54.64, 55.08, 55.14, 62.30,
63.27, 67.26, 67.31, 112.12, 112.29, 116.54, 117.56, 120.98,
121.03, 122.01, 122.06, 122.71, 123.63, 126.49–132.89 (m),
140.34, 140.37, 140.65, 140.68, 141.01, 141.60, 145.02, 145.38,
145.75, 145.90, 146.04, 146.08, 147.27, 147.37, 147.58. 31P NMR
(CDCl3): d 4.00 (major), 3.35 (minor). ESI-MS (m/z): [M+H]+
667.27. Anal. calcd for C42H39N2O4P, C 75.66, H 5.90, N 4.20;
d 1.54 (s, 1.35H), 1.76 (s, 1.65H), 2.16 (s, 1.35H), 2.19 (s,
1.65H), 2.33 (s, 1.65H), 2.57 (s, 1.35H), 3.17 (s, 1.35H), 3.21 (s,
1.65H), 3.27 (s, 1.35H), 3.74 (s, 1.65H), 5.39–5.48 (m, 1.45H),
6.17 (d, J = 10.2 Hz, 0.55H), 6.60–6.67 (m, 2H), 6.83–7.62 (m,
20H), 7.78 (d, J = 8.1 Hz, 0.55H), 7.93 (d, J = 8.2 Hz, 0.45H), 8.54
(s, 0.55H), 8.59 (s, 0.45H). 13C NMR (CDCl3): Due to the complex-
ity of the spectra, signal assignment based on the atropisomerism
is difficult and not shown here. d 17.81, 18.24, 18.64, 20.73,
54.75, 55.10, 60.97, 61.03, 72.31, 72.62, 75.13, 75.26, 110.72,
110.89, 120.08, 120.53, 124.22, 124.67, 126.63, 126.71, 128.00,
128.57–130.63 (m), 131.08, 131.18, 131.21, 131.53, 131.88,
131.98, 132.07, 132.32, 132.64, 133.27, 133.29, 133.44, 133.65,
134.46, 134.81, 134.91, 134.99, 135.20, 135.79, 135.85, 136.07,
140.04, 140.24, 155.64, 155.73, 156.72, 156.75, 157.14, 157.90.
HRMS-ESI (m/z): [MꢀBF4]+ calcd for C44H41N2O2, 629.31626;
found: C 75.22, H 5.82, N 4.19. ½a D25
ꢂ
¼ ꢀ2:05 (c 1.01, CHCl3).
found: 629.31556. ½a D25
¼ ꢀ227:0 (c 1.02, CHCl3).
ꢂ
4.2.7. Imidazolinium zwitterion 2
4.3. Preparation of [Rh(1a)(cod)]2 (Scheme 2)
Phosphate 9 (a mixture of 9a and 9b, 300 mg, 0.45 mmol),
CH(OEt)3 (3.0 mL, 18 mmol, 40 equiv), and NH4BF4 (52.0 mg,
0.50 mmol, 1.1 equiv) were placed in a 10-mL Schlenk flask. The
mixture was stirred at 110 °C for 10 h. After cooling to room tem-
perature, the volatiles were removed under vacuum. The residue
was passed through a short pad of silica gel to give 10 containing
impurities. The mixture was placed in a 10-mL Schlenk flask and
dissolved in THF (1.0 mL). Next, PhSH (0.042 mL, 0.41 mmol,
0.90 equiv) and Et3N (0.069 mL, 0.45 mmol, 1.0 equiv) were added
and the resulting mixture was stirred at room temperature for
13 h. After quenching with H2O, the mixture was extracted with
CH2Cl2. The organic layer was washed with water, dried over
MgSO4, filtered, and concentrated. The residue was purified by sil-
ica gel chromatography (CHCl3 then 10:1 CHCl3/MeOH). Next, the
material was dissolved in CH2Cl2 (10 mL) and satd K2CO3 aq
(10 mL) was added. The resulting mixture was stirred vigorously
at room temperature for 0.5 h. The mixture was then extracted
with CH2Cl2 and the organic layer was washed with water, dried
over MgSO4, filtered, and concentrated to give 2 as a light yellow
solid (106.9 mg, 33% yield in three steps). The title compound 2 ex-
isted as a mixture of atropisomers and the ratio (9:1) was deter-
mined by 1H NMR analysis. Mp: >250 °C. 1H NMR (CDCl3): d 1.15
(s, 3H), 2.10 (s, 3H), 2.48 (s, 3H), 5.27 (d, J = 13.5 Hz, 0.2H), 5.52
(q, J = 9.4 Hz, 1.8H), 6.23 (s, 0.1H), 6.50 (s, 0.9H), 6.67 (s, 0.1H),
6.79 (s, 0.9H), 6.81 (d, J = 7.9 Hz, 1H), 6.98 (d, J = 7.1 Hz, 2H),
7.11–7.64 (m, 17H), 7.77 (dd, J = 7.4, 1.6 Hz, 0.9H), 7.94 (d,
J = 8.2 Hz, 0.1 H), 10.22 (s, 0.1H), 10.54 (s, 0.9H). 13C NMR (CDCl3):
At first, [RhCl(cod)]2 (11.2 mg, 0.023 mmol, 1.0 equiv) and
KOtBu (5.1 mg, 0.045 mmol, 2.0 equiv) were placed in a 5-mL test
tube with a screw cap. Next, THF (0.6 mL) was added to the ves-
sel and the mixture was stirred at room temperature for 1 h. Imi-
dazolium salt 2 (30.0 mg, 0.045 mmol, 2.0 equiv) in THF (0.4 mL)
was then added and the mixture was stirred at room tempera-
ture for 2 h. The volatiles were removed under vacuum, and
the residue was purified by preparative TLC (10:1 CHCl3/MeOH)
to give [Rh(1a)(cod)]2 as a yellow solid (25.4 mg, 64%). Mp:
210–215 °C (decomp). 1H NMR (CDCl3): d 1.39–1.62 (m, 7H),
1.71–1.84 (m, 3H), 1.89 (s, 6H), 1.93–2.13 (m, 4H), 2.16 (s, 6H),
2.23 (s, 6H), 2.28–2.63 (m, 2H), 2.63 (br, 2H), 3.49 (br, 2H),
4.61 (d, J = 5.2 Hz, 2H), 4.82 (br, 2H), 4.99 (br, 2H), 5.75 (d,
J = 7.1 Hz, 2H), 6.36 (d, J = 7.1 Hz, 4H), 6.70–6.85 (m, 8H), 7.05
(t, J = 7.6 Hz, 2H), 7.17–7.50 (m, 26H), 7.62 (dd, J = 7.4, 1.6 Hz,
2H), 7.74 (dd, J = 7.4, 1.6 Hz, 2H), 8.06 (d, J = 8.0 Hz, 2H). 13C
NMR (CDCl3): Due to the complexity of the spectra, signal assign-
ment based on C–P couplings is difficult and not shown here. d
19.18, 19.25, 20.75, 27.38, 27.50, 32.18, 32.45, 63.30, 63.53,
66.15, 66.37, 75.19, 98.09, 98.18, 98.76, 98.86, 122.54, 122.59,
123.95, 124.53, 127.07, 127.57, 127.76, 128.50–128.70 (m),
129.27–130.26 (m), 131.82, 132.58, 132.99, 133.02, 134.58,
134.69, 136.32, 137.81, 138.13, 138.96, 139.09, 139.93, 148.81,
148.94, 150.81, 150.92, 211.38, 212.01. 31P NMR (CDCl3): d 5.74
2
(d, JP-Rh = 8.9 Hz). ESI-MS (m/z): [M+H]+ 1745.44, [M-Rh-1a-
cod+H]+ 873.22. ½a 2D5
¼ ꢀ50:3 (c 1.02, CHCl3).
ꢂ